These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33819956)

  • 1. Factors influencing growth hormone therapy effect during the prepubertal period in small for gestational age children without catch-up growth.
    Kum CD; Rho JG; Park HK; Lee HS; Hwang JS
    Ann Pediatr Endocrinol Metab; 2021 Mar; 26(1):31-37. PubMed ID: 33819956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Dahlgren J; Bjarnason R; Rosberg S; Carlsson LM; Carlsson B; Albertsson-Wikland K
    Eur J Endocrinol; 1997 Oct; 137(4):387-95. PubMed ID: 9368507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Children born small-for-gestational age: postnatal growth and hormonal status.
    Albertsson-Wikland K; Boguszewski M; Karlberg J
    Horm Res; 1998; 49 Suppl 2():7-13. PubMed ID: 9730665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001.
    Lee PA; Chernausek SD; Hokken-Koelega AC; Czernichow P;
    Pediatrics; 2003 Jun; 111(6 Pt 1):1253-61. PubMed ID: 12777538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Height, muscle, fat and bone response to growth hormone in short children with very low birth weight born appropriate for gestational age and small for gestational age.
    Berndt C; Schweizer R; Ranke MB; Binder G; Martin DD
    Horm Res Paediatr; 2014; 82(2):81-8. PubMed ID: 24969628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short children with low birth weight born either small for gestational age or average for gestational age show similar growth response and changes in insulin-like growth factor-1 to growth hormone treatment during the first prepubertal year.
    Ranke MB; Martin DD; Ehehalt S; Schwarze CP; Serra F; Wollmann HA; Schweizer R
    Horm Res Paediatr; 2011; 76(2):104-12. PubMed ID: 21757866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone treatment of short children born small for gestational age: metanalysis of four independent, randomized, controlled, multicentre studies.
    de Zegher F; Albertsson-Wikland K; Wilton P; Chatelain P; Jonsson B; Löfström A; Butenandt O; Chaussain JL
    Acta Paediatr Suppl; 1996 Oct; 417():27-31. PubMed ID: 9055905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone treatment of short children born small for gestational age: reappraisal of the rate of bone maturation over 2 years and metanalysis of height gain over 4 years.
    de Zegher F; Butenandt O; Chatelain P; Albertsson-Wikland K; Jonsson B; Löfström A; Chaussain JL
    Acta Paediatr Suppl; 1997 Nov; 423():207-12. PubMed ID: 9401574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone treatment for extremely low birthweight children born small for gestational age.
    Onuma S; Ida S; Maeyama T; Shoji Y; Etani Y; Kawai M
    Pediatr Int; 2021 Jan; 63(1):46-52. PubMed ID: 32594610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of children born small for gestational age with short stature who qualify for growth hormone treatment.
    Tamaro G; Pizzul M; Gaeta G; Servello R; Trevisan M; Böhm P; Materassi PMA; Macaluso A; Valentini D; Pellegrin MC; Barbi E; Tornese G
    Ital J Pediatr; 2021 Apr; 47(1):82. PubMed ID: 33794966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3M syndrome: Evaluating the clinical and laboratory features and the response of the growth hormone treatment: Single center experience.
    Karacan Küçükali G; Keskin M; Aycan Z; Savaş-Erdeve Ş; Çetinkaya S
    Eur J Med Genet; 2023 Oct; 66(10):104828. PubMed ID: 37673300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A; Simon D; Czernichow P
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed Bone Age Might Accelerate the Response to Human Growth Hormone Treatment in Small for Gestational Age Children with Short Stature.
    Moon JE; Ko CW
    Int J Endocrinol; 2019; 2019():8454303. PubMed ID: 31933639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.